Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, known as C-type lectin domain family 2 member D pseudogene, is annotated in the human genome as a pseudogene, meaning it is a non-functional copy derived from a protein-coding gene[1]. Pseudogenes like this do not encode functional protein products and are not classified as receptors or other druggable targets. They are commonly found throughout the genome and may be remnants of gene duplication events or evolutionary processes, but do not serve as targets for pharmacological intervention. Additional context: C-type lectin domain-containing proteins are a large, diverse family involved in immune recognition and signaling, typically acting as pattern recognition receptors (PRRs) or receptors in cell-cell interactions[2][5][6]. However, only functional, protein-coding members of this family are considered as receptors or therapeutic targets; pseudogenes do not participate in these biological roles. If you are intending to refer to a protein-coding gene such as CLEC2D (C-type lectin domain family 2 member D) or CLEC2B (member B), clarify the target, as these have established functions and could be considered real therapeutic targets[4][9][10]. In contrast, "C-type lectin domain family 2 pseudogene" strictly refers to a non-functional genomic locus and is not actionable in drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-type lectin domain family 2 member D pseudogene.